Details of each database available in SEER*Stat are provided below. We provide a database dictionary and a data description document to describe all the variables in the Research and Research Plus databases. We also provide a summary by SEER*Stat session type of the available databases and main characteristics of each database.

On This Page:

Documentation of SEER*Stat Variables

  • Dictionary of  SEER Variables: Excel (XLSX, 37 KB) or PDF (PDF, 696 KB) - Updated 11/22/2023
    Lists all the variables in the SEER*Stat databases with the following information: NAACCR item number, description and definitions, category name, and availability in the Research, Research Plus, and SEER 22 Limited-Field databases (see SEER Data Change History for more information).
  • Data Description for SEER Research and Research Plus (PDF, 869 KB)
    Provides documentation for each of the variables in the Research and Research Plus databases.

County attribute data from the U.S. Census are also linked to the SEER*Stat databases. Variables available are dependent on the type of database:

  • Research databases have two time-dependent fields available: Median Household Income and Rural-Urban Continuum Codes.
  • Research Plus databases have many fields available from the two types of county attributes: Static and Time-Dependent.

Number of Records in the SEER Data

Registries (Years) All Cases ** Malignant Cases Malignant +
In Situ Cases
SEER 22 (2000-2020) 16,683,417 14,973,585 16,206,855
SEER 22 (2020) 838,085 744,099 807,848
SEER 17 (2000-2020) 9,208,295 8,216,620 8,946,410
SEER 17 (2020) 466,316 411,717 449,887
SEER 12 (1992-2020) 5,242,485 4,715,103 5,118,903
SEER 12 (2020) 204,297 178,978 196,542
SEER 8 (1975-2020) 4,917,840 4,482,721 4,827,344
SEER 8 (2020) 148,821 129,133 142,913

* Registries included in the data are defined in Registry Groupings in SEER Data and Statistics.
** All Cases includes cases coded as benign and borderline malignancy tumors in ICD-O-3.

Databases by SEER*Stat Session Type

Rate Sessions

Incidence - SEER Research Data, 8 Registries, Nov 2022 Sub (1975-2020)

  • SEER 8 covers approximately 8.3% of the U.S. population (based on 2020 census)
  • Most years available, but smallest geographic coverage
  • Rates are available for white, black, other (AI/AN, API)
  • Contains one record for each of 4,917,840 tumors
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1975+
    • Connecticut - 1975+
    • Hawaii - 1975+
    • Iowa - 1975+
    • New Mexico - 1975+
    • Seattle (Puget Sound) - 1975+
    • Utah - 1975+
    • Atlanta (Metropolitan) - 1975+

Incidence - SEER Research Data, 12 Registries, Nov 2022 Sub (1992-2020)

  • SEER 12 covers approximately 12.2% of the U.S. population (based on 2020 census)
  • Rates are available by expanded race (white, black, AI/AN, and API) and Hispanic ethnicity (Hispanic and non-Hispanic)
  • Contains one record for each of 5,242,485 tumors
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1992+
    • Connecticut - 1992+
    • Hawaii - 1992+
    • Iowa - 1992+
    • New Mexico - 1992+
    • Seattle (Puget Sound) - 1992+
    • Utah - 1992+
    • Atlanta (Metropolitan) - 1992+
    • San Jose-Monterey - 1992+
    • Los Angeles - 1992+
    • Alaska Natives - 1992+
    • Rural Georgia - 1992+

Incidence - SEER Research Data, 12 Registries (excl AK), Nov 2022 Sub (1992-2020)

  • SEER 12 covers approximately 12.2% of the U.S. population (based on 2020 census)
  • Rates are available by expanded race (white, black, AI/AN, and API) and Hispanic ethnicity (Hispanic and non-Hispanic)
  • Contains one record for each of 5,230,482 tumors
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1992+
    • Connecticut - 1992+
    • Hawaii - 1992+
    • Iowa - 1992+
    • New Mexico - 1992+
    • Seattle (Puget Sound) - 1992+
    • Utah - 1992+
    • Atlanta (Metropolitan) - 1992+
    • San Jose-Monterey - 1992+
    • Los Angeles - 1992+
    • Rural Georgia - 1992+

Incidence - SEER Research Data, 17 Registries, Nov 2022 Sub (2000-2020)

  • SEER 17 covers approximately 26.5% of the U.S. population (based on 2020 census)
  • Rates are available by expanded race (white, black, AI/AN, and API) and Hispanic ethnicity (Hispanic and non-Hispanic)
  • Includes adjustments for areas impacted by hurricanes Katrina and Rita
  • Contains one record for each of 9,208,295 tumors
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+

Incidence - SEER Research Data, 17 Registries (excl AK), Nov 2022 Sub (2000-2020)

  • SEER 17 covers approximately 26.5% of the U.S. population (based on 2020 census)
  • Rates are available by expanded race (white, black, AI/AN, and API) and Hispanic ethnicity (Hispanic and non-Hispanic)
  • Includes adjustments for areas impacted by hurricanes Katrina and Rita
  • Contains one record for each of 9,198,491 tumors
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+

Incidence - SEER Research Limited-Field Data, 22 Registries, Nov 2022 Sub (2000-2020)

  • Largest geographic coverage available - approximately 47.9% of the U.S. population (based on 2020 census)
  • Rates are available by expanded race (white, black, AI/AN, and API) and Hispanic ethnicity (Hispanic and non-Hispanic)
  • Includes adjustments for areas impacted by hurricanes Katrina and Rita
  • Contains one record for each of 16,683,417 tumors
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+
    • Idaho - 2000+
    • New York - 2000+
    • Massachusetts - 2000+
    • Illinois - 2000+
    • Texas - 2000+

Incidence - SEER Research Limited-Field Data, 22 Registries (excl IL and MA), Nov 2022 Sub (2000-2020)

  • Largest geographic coverage available - approximately 41.9% of the U.S. population (based on 2020 census)
  • Includes additional Cause of Death (COD) and Follow-up variables not available in the other limited-field database.
  • Rates are available by expanded race (white, black, AI/AN, and API) and Hispanic ethnicity (Hispanic and non-Hispanic)
  • Includes adjustments for areas impacted by hurricanes Katrina and Rita
  • Contains one record for each of 14,291,660 tumors
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+
    • Idaho - 2000+
    • New York - 2000+
    • Texas - 2000+

Incidence-Based Mortality - SEER Research Data, 8 Registries, Nov 2022 Sub (1975-2020)

  • SEER 8 covers approximately 8.3% of the U.S. population (based on 2020 census)
  • Used for very specialized analyses, for details refer to Incidence-Based Mortality
  • Rates are available for white, black, other (AI/AN, API)
  • Contains one record for each of 3,103,347 tumors from 2,635,347 individuals. Only patients who have died by the study cut-off date are included in this database.
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1975+
    • Connecticut - 1975+
    • Hawaii - 1975+
    • Iowa - 1975+
    • New Mexico - 1975+
    • Seattle (Puget Sound) - 1975+
    • Utah - 1975+
    • Atlanta (Metropolitan) - 1975+

Incidence-Based Mortality - SEER Research Data, 12 Registries, Nov 2022 Sub (1992-2020)

  • SEER 12 covers approximately 12.2% of the U.S. population (based on 2020 census)
  • Used for very specialized analyses, for details refer to Incidence-Based Mortality
  • Rates are available by expanded race (white, black, AI/AN, and API) and Hispanic ethnicity (Hispanic and non-Hispanic)
  • Contains one record for each of 2,859,687 tumors from 2,444,701 individuals. Only patients who have died by the study cut-off date are included in this database.
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1992+
    • Connecticut - 1992+
    • Hawaii - 1992+
    • Iowa - 1992+
    • New Mexico - 1992+
    • Seattle (Puget Sound) - 1992+
    • Utah - 1992+
    • Atlanta (Metropolitan) - 1992+
    • San Jose-Monterey - 1992+
    • Los Angeles - 1992+
    • Alaska Natives - 1992+
    • Rural Georgia - 1992+

Incidence-Based Mortality - SEER Research Data, 17 Registries, Nov 2022 Sub (2000-2020)

  • SEER 17 covers approximately 26.5% of the U.S. population (based on 2020 census)
  • Used for very specialized analyses, for details refer to Incidence-Based Mortality
  • Rates are available by expanded race (white, black, AI/AN, and API) and Hispanic ethnicity (Hispanic and non-Hispanic)
  • Contains one record for each of 4,452,514 tumors from 3,858,698 individuals. Only patients who have died by the study cut-off date are included in this database.
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+
    • Louisiana - 2000+

Incidence-Based Mortality - SEER Research Plus Limited-Field Data, 22 Registries (excl IL and MA)

  • Largest geographic coverage available - approximately 41.9% of the U.S. population (based on 2020 census)
  • Used for very specialized analyses, for details refer to Incidence-Based Mortality
  • Rates are available by expanded race (white, black, AI/AN, and API) and Hispanic ethnicity (Hispanic and non-Hispanic)
  • Contains one record for each of 6,956,962 tumors from 6,058,641 individuals. Only patients who have died by the study cut-off date are included in this database.
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, …, 85+ years) and single ages with 85+
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+
    • Idaho - 2000+
    • New York - 2000+
    • Texas - 2000+

Incidence - SEER Research Data with Delay-Adjustment, 8 Registries, Malignant Only, Nov 2022 Sub (1975-2020)

  • Allows the calculation of delay-adjusted statistics for all sites combined and several individual cancer sites
  • SEER 8 covers approximately 8.3% of the U.S. population (based on 2020 census)
  • Most years available, but smallest geographic coverage
  • Delay-adjusted rates are available for all races combined, white, black
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Includes only malignant behavior
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1975+
    • Connecticut - 1975+
    • Hawaii - 1975+
    • Iowa - 1975+
    • New Mexico - 1975+
    • Seattle (Puget Sound) - 1975+
    • Utah - 1975+
    • Atlanta (Metropolitan) - 1975+

Incidence - SEER Research Data with Delay-Adjustment, 12 Registries, Malignant Only, Nov 2022 Sub (1992-2020)

  • Allows the calculation of delay-adjusted statistics for all sites combined and several individual cancer sites
  • SEER 12 covers approximately 12.2% of the U.S. population (based on 2020 census)
  • Race and ethnicity groupings available
    • All Races
    • White
    • Black
    • Asian/Pacific Islander
    • Non-Hispanic White
    • Non-Hispanic Black
    • Non-Hispanic PRCDA/AIAN
    • Non-Hispanic Asian/Pacific Islander
    • Hispanic
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Includes only malignant behavior
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1992+
    • Connecticut - 1992+
    • Hawaii - 1992+
    • Iowa - 1992+
    • New Mexico - 1992+
    • Seattle (Puget Sound) - 1992+
    • Utah - 1992+
    • Atlanta (Metropolitan) - 1992+
    • San Jose-Monterey - 1992+
    • Los Angeles - 1992+
    • Alaska Natives - 1992+
    • Rural Georgia - 1992+

Incidence - SEER Research Data with Delay-Adjustment, 17 Registries, Malignant Only, Nov 2022 Sub (2000-2020)

  • Allows the calculation of delay-adjusted statistics for all sites combined and several individual cancer sites
  • SEER 17 covers approximately 26.5% of the U.S. population (based on 2020 census)
  • Includes adjustments for areas impacted by hurricanes Katrina and Rita
  • Race and ethnicity groupings available
    • All Races
    • White
    • Black
    • Asian/Pacific Islander
    • Non-Hispanic White
    • Non-Hispanic Black
    • Non-Hispanic PRCDA/AIAN
    • Non-Hispanic Asian/Pacific Islander
    • Hispanic
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Includes only malignant behavior
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+
    • Louisiana - 2000+

Incidence - SEER Research Limited-Field Data with Delay-Adjustment, 22 Registries, Malignant Only, Nov 2022 Sub (2000-2020)

  • Allows the calculation of delay-adjusted statistics for all sites combined and several individual cancer sites
  • SEER 22 covers approximately 47.9% of the U.S. population (based on 2020 census)
  • Largest geographic coverage for delay-adjusted statistics
  • Includes adjustments for areas impacted by hurricanes Katrina and Rita
  • Race and ethnicity groupings available
    • All Races
    • White
    • Black
    • Asian/Pacific Islander
    • Non-Hispanic White
    • Non-Hispanic Black
    • Non-Hispanic PRCDA/AIAN
    • Non-Hispanic Asian/Pacific Islander
    • Hispanic
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Includes only malignant behavior
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+
    • Idaho - 2000+
    • New York - 2000+
    • Massachusetts - 2000+
    • Illinois - 2000+
    • Texas - 2000+

Incidence - SEER Research Plus Data with Delay-Adjustment by Stage, 17 Registries, Breast and Prostate, Malignant Only, Nov 2022 Sub (2000-2020)

  • Only available with the Research Plus data
  • Allows the calculation of delay-adjusted statistics for breast and prostate cancers by stage
  • SEER 17 covers approximately 26.5% of the U.S. population (based on 2020 census)
  • Includes adjustments for areas impacted by hurricanes Katrina and Rita
  • Race and ethnicity groupings available
    • All Races
    • White
    • Black
    • Asian/Pacific Islander
    • Non-Hispanic White
    • Non-Hispanic Black
    • Non-Hispanic PRCDA/AIAN
    • Non-Hispanic Asian/Pacific Islander
    • Hispanic
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Includes only malignant behavior
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+
    • Louisiana - 2000+

Incidence - SEER Research Plus Limited-Field Data with Delay-Adjustment by Stage, 22 Registries, Breast and Prostate, Malignant Only, Nov 2022

  • Only available with the Research Plus data
  • Allows the calculation of delay-adjusted statistics for breast and prostate cancers by stage
  • SEER 22 covers approximately 47.9% of the U.S. population (based on 2020 census)
  • Largest geographic coverage for delay-adjusted statistics
  • Includes adjustments for areas impacted by hurricanes Katrina and Rita
  • Race and ethnicity groupings available
    • All Races
    • White
    • Black
    • Asian/Pacific Islander
    • Non-Hispanic White
    • Non-Hispanic Black
    • Non-Hispanic PRCDA/AIAN
    • Non-Hispanic Asian/Pacific Islander
    • Hispanic
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Includes only malignant behavior
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+
    • Idaho - 2000+
    • New York - 2000+
    • Massachusetts - 2000+
    • Illinois - 2000+
    • Texas - 2000+

Case Listing and Frequency Sessions

Incidence - SEER Research Data, 8 Registries, Nov 2022 Sub (1975-2020)

  • SEER 8 covers approximately 8.3% of the U.S. population (based on 2020 census)
  • Most years available, but smallest geographic coverage
  • Contains one record for each of 4,917,840 tumors
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1975+
    • Connecticut - 1975+
    • Hawaii - 1975+
    • Iowa - 1975+
    • New Mexico - 1975+
    • Seattle (Puget Sound) - 1975+
    • Utah - 1975+
    • Atlanta (Metropolitan) - 1975+

Incidence - SEER Research Data, 12 Registries, Nov 2022 Sub (1992-2020)

  • SEER 12 covers approximately 12.2% of the U.S. population (based on 2020 census)
  • Contains one record for each of 5,242,485 tumors
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1992+
    • Connecticut - 1992+
    • Hawaii - 1992+
    • Iowa - 1992+
    • New Mexico - 1992+
    • Seattle (Puget Sound) - 1992+
    • Utah - 1992+
    • Atlanta (Metropolitan) - 1992+
    • San Jose-Monterey - 1992+
    • Los Angeles - 1992+
    • Alaska Natives - 1992+
    • Rural Georgia - 1992+

Incidence - SEER Research Data, 17 Registries, Nov 2022 Sub (2000-2020)

  • SEER 17 covers approximately 26.5% of the U.S. population (based on 2020 census)
  • Contains one record for each of 9,208,295 tumors.
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+

Incidence - SEER Limited-Field Research Data, 22 Registries, Nov 2022 Sub (2000-2020)

  • Covers approximately 47.9% of the U.S. population (based on 2020 census)
  • Contains one record for each 16,683,417 tumors
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+
    • Idaho - 2000+
    • New York - 2000+
    • Massachusetts - 2000+
    • Illinois - 2000+
    • Texas - 2000+

Incidence - SEER Limited-Field Research Data, 22 Registries (excl IL and MA), Nov 2022 Sub (2000-2020)

  • Covers approximately 41.9% of the U.S. population (based on 2020 census)
  • Includes additional Cause of Death (COD) and Follow-up variables not available in the other limited-field database.
  • Contains one record for each 14,291,660 tumors
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+
    • Idaho - 2000+
    • New York - 2000+
    • Texas - 2000+

Prevalence Sessions

Incidence - SEER Research Data, 8 Registries, Nov 2022 Sub (1975-2020)

  • SEER 8 covers approximately 8.3% of the U.S. population (based on 2020 census)
  • Most years available, but smallest geographic coverage
  • Prevalence proportions are available for white, black, other (AI/AN, API)
  • Contains one record for each of 4,917,840 tumors
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1975+
    • Connecticut - 1975+
    • Hawaii - 1975+
    • Iowa - 1975+
    • New Mexico - 1975+
    • Seattle (Puget Sound) - 1975+
    • Utah - 1975+
    • Atlanta (Metropolitan) - 1975+

Incidence - SEER Research Data, 12 Registries, Nov 2022 Sub (1992-2020)

  • SEER 12 covers approximately 12.2% of the U.S. population (based on 2020 census)
  • Most years available for expanded race/ethnicity rates/prevalence proportions
  • Prevalence proportions are available by expanded race (white, black, AI/AN, and API) and Hispanic ethnicity (Hispanic and non-Hispanic)
  • Contains one record for each of 5,242,485 tumors
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1992+
    • Connecticut - 1992+
    • Hawaii - 1992+
    • Iowa - 1992+
    • New Mexico - 1992+
    • Seattle (Puget Sound) - 1992+
    • Utah - 1992+
    • Atlanta (Metropolitan) - 1992+
    • San Jose-Monterey - 1992+
    • Los Angeles - 1992+
    • Alaska Natives - 1992+
    • Rural Georgia - 1992+

Incidence - SEER Research Data, 17 Registries, Nov 2022 Sub (2000-2020)

  • SEER 17 covers approximately 26.5% of the U.S. population (based on 2020 census)
  • Prevalence proportions are available by expanded race (white, black, AI/AN, and API) and Hispanic ethnicity (Hispanic and non-Hispanic)
  • Includes adjustments for areas impacted by hurricanes Katrina and Rita
  • Contains one record for each of 9,208,295 tumors
  • Two age variables are available: 19 age groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+

Incidence - SEER Limited-Field Research Data, 22 Registries (excl IL and MA), Nov 2022 Sub (2000-2020)

  • Largest geographic coverage available for prevalence - approximately 41.9% of the U.S. population (based on 2020 census)
  • Includes additional Cause of Death (COD) and Follow-up variables not available in the other limited-field database.
  • Includes adjustments for areas impacted by hurricanes Katrina and Rita
  • Contains one record for each 14,291,660 tumors
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+
    • Idaho - 2000+
    • New York - 2000+
    • Texas - 2000+

Survival and Left-Truncated Life Table Sessions

Incidence - SEER Research Data, 8 Registries, Nov 2022 Sub (1975-2020)

  • SEER 8 covers approximately 8.3% of the U.S. population (based on 2020 census)
  • Most years available, but smallest geographic coverage
  • Contains one record for each of 4,917,840 tumors
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1975+
    • Connecticut - 1975+
    • Hawaii - 1975+
    • Iowa - 1975+
    • New Mexico - 1975+
    • Seattle (Puget Sound) - 1975+
    • Utah - 1975+
    • Atlanta (Metropolitan) - 1975+

Incidence - SEER Research Data, 12 Registries, Nov 2022 Sub (1992-2020)

  • SEER 12 covers approximately 12.2% of the U.S. population (based on 2020 census)
  • Contains one record for each of 5,242,485 tumors
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1992+
    • Connecticut - 1992+
    • Hawaii - 1992+
    • Iowa - 1992+
    • New Mexico - 1992+
    • Seattle (Puget Sound) - 1992+
    • Utah - 1992+
    • Atlanta (Metropolitan) - 1992+
    • San Jose-Monterey - 1992+
    • Los Angeles - 1992+
    • Alaska Natives - 1992+
    • Rural Georgia - 1992+

Incidence - SEER Research Data, 17 Registries, Nov 2022 Sub (2000-2020)

  • SEER 17 covers approximately 26.5% of the U.S. population (based on 2020 census)
  • Includes adjustments for areas impacted by hurricanes Katrina and Rita
  • Contains one record for each of 9,208,295 tumors
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+

Incidence - SEER Limited-Field Research Data, 22 Registries (excl IL and MA), Nov 2022 Sub (2000-2020)

  • Largest geographic coverage available for survival - approximately 41.9% of the U.S. population (based on 2020 census)
  • Includes additional Cause of Death (COD) and Follow-up variables not available in the other limited-field database.
  • Includes adjustments for areas impacted by hurricanes Katrina and Rita
  • Contains one record for each 14,291,660 tumors
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Alaska Natives - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+
    • Idaho - 2000+
    • New York - 2000+
    • Texas - 2000+

MP-SIR/SMR Sessions

Incidence - SEER Research Data, 8 Registries, Nov 2022 Sub (1975-2020)

  • Covers approximately 8.3% of the U.S. population (based on 2020 census)
  • Most years available, but smallest geographic coverage
  • Associated referent rates are for subsequent primary cancer diagnoses
  • Associated referent rates are available for white, black, other (AI/AN, API)
  • Contains one record for each of 4,917,840 tumors
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1975+
    • Connecticut - 1975+
    • Hawaii - 1975+
    • Iowa - 1975+
    • New Mexico - 1975+
    • Seattle (Puget Sound) - 1975+
    • Utah - 1975+
    • Atlanta (Metropolitan) - 1975+

Incidence - SEER Research Data, 12 Registries (excl AK), Nov 2022 Sub (1992-2020)

  • Covers approximately 12.2% of the U.S. population (based on 2020 census)
  • Associated referent rates are for subsequent primary cancer diagnoses
  • Associated referent rates are available for white, black, other (AI/AN, API)
  • Contains one record for each of 5,230,482 tumors
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1992+
    • Connecticut - 1992+
    • Hawaii - 1992+
    • Iowa - 1992+
    • New Mexico - 1992+
    • Seattle (Puget Sound) - 1992+
    • Utah - 1992+
    • Atlanta (Metropolitan) - 1992+
    • San Jose-Monterey - 1992+
    • Los Angeles - 1992+
    • Alaska Natives - 1992+
    • Rural Georgia - 1992+

Incidence - SEER Research Data, 17 Registries (excl AK), Nov 2022 Sub (2000-2020)

  • Largest geographic coverage available for MP-SIRs - approximately 26.5% of the U.S. population (based on 2020 census)
  • Associated referent rates are for subsequent primary cancer diagnoses
  • Associated referent rates are available for white, black, other (AI/AN, API)
  • Contains one record for each of 9,198,491 tumors
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+

Incidence - SEER Research Data, 8 Registries, Nov 2022 Sub (1975-2020) for SMRs

  • Covers approximately 8.3% of the U.S. population (based on 2020 census)
  • Most years available, but smallest geographic coverage
  • Associated referent rates are for mortality
  • Associated referent rates are available for white, black, other (AI/AN, API)
  • Contains one record for each of 4,917,840 tumors
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1975+
    • Connecticut - 1975+
    • Hawaii - 1975+
    • Iowa - 1975+
    • New Mexico - 1975+
    • Seattle (Puget Sound) - 1975+
    • Utah - 1975+
    • Atlanta (Metropolitan) - 1975+

Incidence - SEER Research Data, 12 Registries (excl AK), Nov 2022 Sub (1992-2020) for SMRs

  • Covers approximately 12.2% of the U.S. population (based on 2020 census)
  • Associated referent rates are for mortality
  • Associated referent rates are available for white, black, other (AI/AN, API)
  • Contains one record for each of 5,230,482 tumors
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 1992+
    • Connecticut - 1992+
    • Hawaii - 1992+
    • Iowa - 1992+
    • New Mexico - 1992+
    • Seattle (Puget Sound) - 1992+
    • Utah - 1992+
    • Atlanta (Metropolitan) - 1992+
    • San Jose-Monterey - 1992+
    • Los Angeles - 1992+
    • Alaska Natives - 1992+
    • Rural Georgia - 1992+

Incidence - SEER Research Data, 17 Registries (excl AK), Nov 2022 Sub (2000-2020) for SMRs

  • Largest geographic coverage available MP-SMRs - approximately 26.5% of the U.S. population (based on 2020 census)
  • Associated referent rates are for mortality
  • Associated referent rates are available for white, black, other (AI/AN, API)
  • Contains one record for each of 9,198,491 tumors
  • Some variables are not available in SEER*Stat case listings.
  • Geographic areas (registries) and years covered
    • San Francisco-Oakland SMSA - 2000+
    • Connecticut - 2000+
    • Hawaii - 2000+
    • Iowa - 2000+
    • New Mexico - 2000+
    • Seattle (Puget Sound) - 2000+
    • Utah - 2000+
    • Atlanta (Metropolitan) - 2000+
    • San Jose-Monterey - 2000+
    • Los Angeles - 2000+
    • Rural Georgia - 2000+
    • California excluding SF/SJM/LA - 2000+
    • Kentucky - 2000+
    • Louisiana - 2000+
    • New Jersey - 2000+
    • Greater Georgia - 2000+